Holding pharma stocks? Minor correction may offer buying opportunity, says analyst
Bathini’s comments come at a time when investors are reassessing sector leadership in a volatile market, with pharma stocks reacting to a mix of regulatory, product and business-specific developments.
Attribution
This digest is published with acknowledgment to Business Today. For the complete analysis, headnotes, and citations, please refer to the source.
Read on Business Today